home > pmps

Pharmaceutical Manufacturing and Packing Sourcer


Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.


For further information please contact:

Catherine Dillon

Angela Cottrell

We're also on Twitter! Follow us @PMPSmag

Click here to view the digital version of PMPS


Featured in this issue
Track and Trace

A Numbers Game

In response to global counterfeiting, steps are being taken to implement the wider use of serialisation. By acting now, Kelly Wrich and Chris Bishop at 3M Drug Delivery Systems suggest that companies can ensure a smoother transition and uninterrupted supplies.
Digital Supply Chain
Business Process Outsourcing

The Digital Age

In line with technology improvements and advances in quality and standardisation of care, companies need to adapt to guarantee they are meeting rising patient expectations. Alan Cox at The Indigo Lighthouse Group gives details.
  Regional Focus: Latin America
Market Report: South America

New Horizons

Latin America looks to be the destination of choice for pharmaceutical companies seeking global expansion, but Shanshan Wang at Business Monitor International reminds drug-makers that the region still faces volatile economic and political changes.

Edited by
Dr Graham Hughes
Consultant in
Published quarterly in
February, May,
August and November
Banner of GDP Temp Management Logistics.PMPS on Samedan
Banner of Samedan app.PMPS on Samedan
Industry Events

Orphan Drugs and Rare Diseases

20-21 October 2014, Holiday Inn Regents Park Hotel, London, UK

As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and theEarly Access to Medicines Scheme was introduced. Key implementation of this will be a factor into further commercialisation and developments.
More info >>

News and Press Releases

Nelipak® Corporation Acquires Flexpak Corporation

Cranston, RI (July 28th 2014) – Nelipak® Corporation (“Nelipak”) announced today that it has closed on the acquisition of Debond Corporation (dba Flexpak Corporation) (“Flexpak”). The business will be owned by Nelipak and operate under the name of Nelipak® Healthcare Packaging.
More info >>

air transport logo


White Papers



Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm. Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little. Now, after several years of industry discussion and recent industry collaboration1, there’s solidifying consensus that adoption of data-driven monitoring can substantially improve study quality, safety, and also reduce monitoring costs, which today account for 15-30% of total study costs. Data-driven monitoring represents a major departure from traditional monitoring in which clinical research associates (CRA) typically visit sites on a fixed schedule. Instead, data-driven monitoring leverages eClinical technology (EDC, CTMS, RTSM) to turn monitoring into a flexible, responsive, team-based activity.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement